| 1 | Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. (Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R) J Hematol Oncol 2023 Nov 09;16(1):111 |
| 2 | Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning. (Arshad S, Fang X, Ahn KW, Kaur M, Scordo M, Sauter CS, Furqan F, Awan FT, Hamadani M) Bone Marrow Transplant 2023 Nov;58(11):1203-1208 1 Citation |
| 2 | Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective. (Eraky AM, Beck RT, Treffy RW, Aaronson DM, Hedayat H) J Integr Neurosci 2023 May 15;22(3):73 3 Citations |
| 3 | Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. (Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA) Transplant Cell Ther 2023 Jun;29(6):380.e1-380.e9 |
| 1 | Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis. (Epperla N, Reljic T, Chowdhury SM, Ferreri AJM, Kumar A, Hamadani M) Hematol Oncol 2023 Feb;41(1):88-96 5 Citations |
| 1 | A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors. (Metts J, Harrington B, Salman E, Bradfield SM, Flanary J, Mosha M, Amankwah E, Stapleton S) Childs Nerv Syst 2022 May;38(5):919-928 2 Citations |
| 1 | A case of primary CNS embryonal rhabdomyosarcoma with PAX3-NCOA2 fusion and systematic meta-review. (Tanaka R, Inoue K, Yamada Y, Yoshida M, Shima H, Ito J, Okita H, Miwa T, Kato M, Shimada H) J Neurooncol 2021 Sep;154(2):247-256 5 Citations |
| 2 | Papillary glioneuronal tumors: Distinctive cytological characteristics and cyto-histologic correlation. (Puzyrenko A, Cochran E, Giorgadze T, Nomani L) Ann Diagn Pathol 2021 Aug;53:151757 3 Citations |
| 1 | Extranodal Marginal Zone Lymphoma of the Central Nervous System Includes Parenchymal-Based Cases With Characteristic Features. (Nomani L, Cotta CV, Hsi ED, Ferry JA, Cook JR) Am J Clin Pathol 2020 Jun 08;154(1):124-132 9 Citations |
| 1 | Is ibrutinib associated with disseminated cryptococcosis with CNS involvement? (Abid MB, Stromich J, Gundacker ND) Cancer Biol Ther 2019;20(2):138-140 7 Citations |
| 1 | Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 May 01;82(5):595-603 10 Citations |
| 1 | Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. (Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Ader J, Diller L, Schwartz CL) Pediatr Blood Cancer 2017 Oct;64(10) 12 Citations |
| 3 | Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ) Biol Blood Marrow Transplant 2017 Aug;23(8):1320-1326 8 Citations |
| 2 | Marizomib for central nervous system-multiple myeloma. (Badros A, Singh Z, Dhakal B, Kwok Y, MacLaren A, Richardson P, Trikha M, Hari P) Br J Haematol 2017 Apr;177(2):221-225 48 Citations |
| 1 | Divergent viral presentation among human tumors and adjacent normal tissues. (Cao S, Wendl MC, Wyczalkowski MA, Wylie K, Ye K, Jayasinghe R, Xie M, Wu S, Niu B, Grubb R 3rd, Johnson KJ, Gay H, Chen K, Rader JS, Dipersio JF, Chen F, Ding L) Sci Rep 2016 Jun 24;6:28294 53 Citations |
| 1 | Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. (Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP) J Clin Oncol 2016 May 10;34(14):1620-5 100 Citations |
| 1 | Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. (Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday R, Chavez JC, Song K, Zelenetz AD, Gandhi M, Shah N, Fenske TS, Jaso J, Medeiros LJ, Yang DT, Nabhan C) Cancer 2016 Feb 15;122(4):559-64 64 Citations |
| 1 | Comparing Angiographic Devascularization with Histologic Penetration after Preoperative Tumor Embolization with Onyx: What Indicates an Effective Procedure? (Grandhi R, Hunnicutt CT, Harrison G, Zwagerman NT, Snyderman CH, Gardner PA, Hartman DJ, Horowitz M) J Neurol Surg A Cent Eur Neurosurg 2015 Jul;76(4):309-17 6 Citations |
| 1 | The natural history of intravascular lymphomatosis. (Fonkem E, Lok E, Robison D, Gautam S, Wong ET) Cancer Med 2014 Aug;3(4):1010-24 59 Citations |
| 1 | Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus. (Piha-Paul SA, Shin SJ, Vats T, Guha-Thakurta N, Aaron J, Rytting M, Kleinerman E, Kurzrock R) Anticancer Res 2014 Apr;34(4):1939-45 24 Citations |
| 1 | Feasibility of conducting long-term follow-up of children and infants treated for CNS tumors on the same cooperative group clinical trial protocol. (Hoag J, Kupst MJ, Briere ME, Mabbott D, Elkin TD, Trask CL, Isenberg J, Holm S, Ambler C, Strother DR) J Clin Psychol Med Settings 2014 Jun;21(2):136-43 1 Citation |
| 1 | Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction. (Chrzanowska-Wodnicka M) Exp Cell Res 2013 Sep 10;319(15):2350-9 41 Citations |
| 4 | Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. (Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, Maharaj D, Munker R, Phillips GL, Rizzieri DA, Rowlings PA, Saber W, Satwani P, Waller EK, Maloney DG, Montoto S, Laport GG, Vose JM, Lazarus HM, Hari PN) Br J Haematol 2013 Sep;162(5):648-56 23 Citations |
| 1 | Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature. (Hall WA, Ali AN, Gullett N, Crocker I, Landry JC, Shu HK, Prabhu R, Curran W) Cancer 2012 Nov 01;118(21):5331-8 14 Citations |
| 1 | Central nervous system Hodgkin lymphoma: case report and review of the literature. (Torgerson S, Olteanu H, Tinguely M, Fenske TS) J Neurooncol 2011 Apr;102(2):329-34 7 Citations |
| 1 | Current management of primary central nervous system lymphoma. (Schultz CJ, Bovi J) Int J Radiat Oncol Biol Phys 2010 Mar 01;76(3):666-78 36 Citations |
| 1 | Treatment of a CNS relapse while on therapy for Burkitt lymphoma. (Burke MJ, Dayton V) Pediatr Blood Cancer 2009 Feb;52(2):290-2 2 Citations |
| 2 | Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Leukemia 2008 Feb;22(2):281-6 48 Citations |
| 1 | Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. (Zaidi A, Kampalath B, Peltier WL, Vesole DH) Leuk Lymphoma 2004 Apr;45(4):777-80 54 Citations |
| 2 | Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. (Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL) Arch Pathol Lab Med 2003 Feb;127(2):208-12 71 Citations |
| 1 | Cerebrospinal fluid involvement in mantle cell lymphoma. (Valdez R, Kroft SH, Ross CW, Schnitzer B, Singleton TP, Peterson LC, Finn WG) Mod Pathol 2002 Oct;15(10):1073-9 31 Citations |
| 1 | Clinical indications for brachytherapy. (Erickson B, Wilson JF) J Surg Oncol 1997 Jul;65(3):218-27 18 Citations |
